Pharmacovigilance study of beta adrenergic receptor antagonists in patients visiting department of medicine of a tertiary care hospital, Surendranagar, Gujarat, India

Authors

  • Madhav Trivedi Department of Pharmacology, C. U. Shah Medical College, Surendranagar, Gujarat, India
  • Tejas Acharya Department of Pharmacology, C. U. Shah Medical College, Surendranagar, Gujarat, India
  • Fenilkumar Kotadiya Department of Pharmacology, M.P. Shah Medical College, Jamnagar, Gujarat, India
  • Ritesh Vekariya Department of Pharmacology, C. U. Shah Medical College, Surendranagar, Gujarat, India
  • Dimple Mehta Department of Pharmacology, C. U. Shah Medical College, Surendranagar, Gujarat, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20164086

Keywords:

Beta blockers, Pharmacovigilance, WHO-UMC scale

Abstract

Background: The objective of this study was to evaluate incidence, patterns, and severity of Beta blockers induced adverse drug reactions (ADR).

Methods: A total of 500 patients taking Beta blockers were enrolled in the study by taking an informed consent. Reporting of all Beta blockers-induced ADRs was done by filling CDSCO ADR form. All ADR reports were evaluated according to WHO-UMC causality assessment scale.

Results: A total of 64 ADRs (48 males and 18 females) was observed in 500 patients taking beta blockers. Of 64 ADRs, 20 (31.25%) were mild, 34 (53.13%) were moderate, and 10 (15.62%) were classified as severe. 26 (40.62%) ADRs were classified as Probable, followed by 22 (34.38%) ADRs were in Possible category, 8 (12.5%) were in certain category, 4 (6.25%) ADRs were unlikely and 4(6.25%) ADRs were Conditional. Among 64 ADRs, 22 (3.43%) patients developed bronchospasm, 10 (1.56%) bradycardia, 8 (1.25%) fatigue, 8 (1.25%) nausea/GI upset, 4 (0.62%) erectile dysfunction, 4 (0.62%) dry cough, altered lipid profile, insomnia, night mares and diarrhea are other rare ADRs.

Conclusions: Incidence of ADRs by beta blockers is 12.80% with bronchospasm as the most common ADR followed by bradycardia. As atenolol is most frequently used beta blocker, ADRs due to atenolol are more common.

References

Bonow RO, Smaha LA, Smith SC Jr, Mensah GA, Lenfant C. World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic. Lenfant C Circulation. 2002;106(13):1602-5.

LaPointe NM, Jollis JG. Medication errors in hospitalized cardiovascular patients. Arch Intern Med. 2003;163(12):1461-6.

Jose J, Rao GM. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Pharmacol Res. 2006;226-33.

Prakash S. Pharmacovigilance in India. Indian J Pharmacol. 2007;39:123.

WHO. The importance of pharmacovigilance, safety monitoring of medical products. WHO Geneva, 2002.

Edward IR, Aronson JK. Adverse drug reactions: Definitions, diagnosis, and management. Lancet. 2000;356:12550-9.

Tripathi KD, Antiadrenergic drugs and drugs for glaucoma. Essentials of Medical Pharmacology, 6th ed. New Delhi: Jaypee Brothers. 2009:140-57.

Central drug standard control organization. Pharmacovigilance Programme of India; 2011 [Cited in 2011] Available from internet: http://cdsco.nic.in/ADR_form_PvPI.pdf.

The Uppsala monitoring centre. The use of WHO-UMC system for standardized case causality assessment; 2011 [Cited in 2011]. Available from internet: http://who-umc.org/Graphics/24734.pdf.

Jose J, Rao GM. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Pharmacol Res. 2006;226-33.

Lewis CE, Grandits GA, Flack J, McDonals R, Elmer PJ. Efficacy and tolerance of anti-hypertensive treatment to men and women with stage-1 diastolic hypertension: Result of the treatment of mild hypertension study. Arch Intern Med. 1996;156:377-85.

Montastruc JL, Lapeyre-Mestre M, Bagheri H, Fooladi A. Gender differences in adverse drug reactions: Analysis of spontaneous reports to a regional pharmacovigilance center in France. Fundam Clinical Pharmacol. 2002;16:343-6.

Kanjanarat P1, Winterstein AG, Johns TE, Hatton RC, Gonzalez-Rothi R, Segal R. Nature of preventable adverse drug events in hospitals: a literature review. Am J Health Syst Pharm. 2003;60(17):1750-9.

Palanisamy S, Kottur SG, Rajasekaran A. A study on assessment, monitoring and reporting of adverse drug reaction in Indian hospital. Asian J Pharm Clin Res. 2011;4(3):112-6.

Hussain A, Aqil M, Alam MS, Khan MR, Kapur P, Pillai KK. A Pharmacovigilance Study of Antihypertensive Medicines at a South Delhi Hospital. Indian J Pharm Sci. 2009;71(3):338-41.

A study of atenolol side effects[Internet] 2011 Oct12 Available from: http://www.ehealthme.com/q/atenolol-side-effects-drug-interactions.

Downloads

Published

2016-12-21

How to Cite

Trivedi, M., Acharya, T., Kotadiya, F., Vekariya, R., & Mehta, D. (2016). Pharmacovigilance study of beta adrenergic receptor antagonists in patients visiting department of medicine of a tertiary care hospital, Surendranagar, Gujarat, India. International Journal of Basic & Clinical Pharmacology, 5(6), 2332–2335. https://doi.org/10.18203/2319-2003.ijbcp20164086

Issue

Section

Original Research Articles